High-MCM2 index has been shown to correlate with high Ki-67 labeling [24] and has been shown to be a prognostic marker in a variety of human malignancies, including cancers of the esophagus, prostate, stomach and in diffuse large B-cell lymphoma [24–28]. This evidence concerns the gene MKI67 and esophageal cancer.